BioRem Statistics

Total Valuation

BioRem has a market cap or net worth of CAD 30.30 million. The enterprise value is 28.64 million.

Market Cap	30.30M
Enterprise Value	28.64M

Important Dates

The last earnings date was Friday, April 4, 2025.

Earnings Date	Apr 4, 2025
Ex-Dividend Date	n/a

Share Statistics

BioRem has 15.70 million shares outstanding. The number of shares has increased by 0.59% in one year.

Current Share Class	n/a
Shares Outstanding	15.70M
Shares Change (YoY)	+0.59%
Shares Change (QoQ)	-16.00%
Owned by Insiders (%)	1.99%
Owned by Institutions (%)	n/a
Float	15.39M

Valuation Ratios

The trailing PE ratio is 12.06.

PE Ratio	12.06
Forward PE	n/a
PS Ratio	0.81
PB Ratio	2.85
P/TBV Ratio	2.85
P/FCF Ratio	9.14
P/OCF Ratio	8.22
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.88, with an EV/FCF ratio of 8.64.

EV / Earnings	9.41
EV / Sales	0.77
EV / EBITDA	5.88
EV / EBIT	6.52
EV / FCF	8.64

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.33.

Current Ratio	1.63
Quick Ratio	1.34
Debt / Equity	0.33
Debt / EBITDA	0.73
Debt / FCF	1.07
Interest Coverage	22.56

Financial Efficiency

Return on equity (ROE) is 35.10% and return on invested capital (ROIC) is 21.89%.

Return on Equity (ROE)	35.10%
Return on Assets (ROA)	10.44%
Return on Invested Capital (ROIC)	21.89%
Return on Capital Employed (ROCE)	32.57%
Revenue Per Employee	1.10M
Profits Per Employee	89,522
Employee Count	34
Asset Turnover	1.42
Inventory Turnover	14.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.03% in the last 52 weeks. The beta is 0.69, so BioRem's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-2.03%
50-Day Moving Average	2.34
200-Day Moving Average	2.55
Relative Strength Index (RSI)	39.01
Average Volume (20 Days)	53,421

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioRem had revenue of CAD 37.42 million and earned 3.04 million in profits. Earnings per share was 0.16.

Revenue	37.42M
Gross Profit	10.06M
Operating Income	4.39M
Pretax Income	4.15M
Net Income	3.04M
EBITDA	4.67M
EBIT	4.39M
Earnings Per Share (EPS)	0.16

Full Income Statement

Balance Sheet

The company has 5.21 million in cash and 3.56 million in debt, giving a net cash position of 1.66 million or 0.11 per share.

Cash & Cash Equivalents	5.21M
Total Debt	3.56M
Net Cash	1.66M
Net Cash Per Share	0.11
Equity (Book Value)	10.63M
Book Value Per Share	0.68
Working Capital	9.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.69 million and capital expenditures -372,001, giving a free cash flow of 3.31 million.

Operating Cash Flow	3.69M
Capital Expenditures	-372,001
Free Cash Flow	3.31M
FCF Per Share	0.21

Full Cash Flow Statement

Margins

Gross margin is 26.87%, with operating and profit margins of 11.74% and 8.13%.

Gross Margin	26.87%
Operating Margin	11.74%
Pretax Margin	11.09%
Profit Margin	8.13%
EBITDA Margin	12.49%
EBIT Margin	11.74%
FCF Margin	8.85%

Dividends & Yields

BioRem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.59%
Shareholder Yield	-0.59%
Earnings Yield	10.05%
FCF Yield	10.94%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioRem has an Altman Z-Score of 3.39.

Altman Z-Score	3.39
Piotroski F-Score	n/a